MedTrace Logo

Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle

NCT00735657 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-12-02

No results posted yet for this study

Summary

Periocular blockade with 12.5 mm needle is as effective as block with 25 mm needle for patients undergoing Pars Plana Vitrectomy.

Conditions

  • Retinal Disorders

Interventions

DEVICE

needle

Peribulbar blockade with standard (25 mm) needle

DEVICE

needle

Peribulbar blockade with short (12.5 mm) needle

PROCEDURE

Pars Plana Vitrectomy

Peribulbar block

Sponsors & Collaborators

  • King Khaled Eye Specialist Hospital

    lead OTHER_GOV

Principal Investigators

  • Waleed Riad, MD · KKESH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-08-31
Completion
2010-12-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00735657 on ClinicalTrials.gov